Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease

Abstract Animal studies have indicated that increased blood-brain barrier (BBB) permeability and inflammatory cell infiltration are involved during the progression of Parkinson’s disease (PD). This study used C16, a peptide that competitively binds to integrin αvβ3 and inhibits inflammatory cell inf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hua-Ying Cai, Xiao-Xiao Fu, Hong Jiang, Shu Han
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/53a99f909adf4089ae3b45ded311663d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:53a99f909adf4089ae3b45ded311663d
record_format dspace
spelling oai:doaj.org-article:53a99f909adf4089ae3b45ded311663d2021-12-02T19:16:11ZAdjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease10.1038/s41531-021-00233-32373-8057https://doaj.org/article/53a99f909adf4089ae3b45ded311663d2021-10-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00233-3https://doaj.org/toc/2373-8057Abstract Animal studies have indicated that increased blood-brain barrier (BBB) permeability and inflammatory cell infiltration are involved during the progression of Parkinson’s disease (PD). This study used C16, a peptide that competitively binds to integrin αvβ3 and inhibits inflammatory cell infiltration, as well as angiopoietin-1 (Ang-1), an endothelial growth factor crucial for blood vessel protection, to reduce inflammation and improve the central nervous system (CNS) microenvironment in murine models of PD. The combination of C16 and Ang-1 yielded better results compared to the individual drugs alone in terms of reducing dopaminergic neuronal apoptosis, ameliorating cognitive impairment, and electrophysiological dysfunction, attenuating inflammation in the CNS microenvironment, and improving the functional disability in PD mice or rats. These results suggest neuroprotective and anti-inflammatory properties of the C16 peptide plus Ang-1 in PD.Hua-Ying CaiXiao-Xiao FuHong JiangShu HanNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Hua-Ying Cai
Xiao-Xiao Fu
Hong Jiang
Shu Han
Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
description Abstract Animal studies have indicated that increased blood-brain barrier (BBB) permeability and inflammatory cell infiltration are involved during the progression of Parkinson’s disease (PD). This study used C16, a peptide that competitively binds to integrin αvβ3 and inhibits inflammatory cell infiltration, as well as angiopoietin-1 (Ang-1), an endothelial growth factor crucial for blood vessel protection, to reduce inflammation and improve the central nervous system (CNS) microenvironment in murine models of PD. The combination of C16 and Ang-1 yielded better results compared to the individual drugs alone in terms of reducing dopaminergic neuronal apoptosis, ameliorating cognitive impairment, and electrophysiological dysfunction, attenuating inflammation in the CNS microenvironment, and improving the functional disability in PD mice or rats. These results suggest neuroprotective and anti-inflammatory properties of the C16 peptide plus Ang-1 in PD.
format article
author Hua-Ying Cai
Xiao-Xiao Fu
Hong Jiang
Shu Han
author_facet Hua-Ying Cai
Xiao-Xiao Fu
Hong Jiang
Shu Han
author_sort Hua-Ying Cai
title Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
title_short Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
title_full Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
title_fullStr Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
title_full_unstemmed Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson’s disease
title_sort adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of parkinson’s disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/53a99f909adf4089ae3b45ded311663d
work_keys_str_mv AT huayingcai adjustingvascularpermeabilityleukocyteinfiltrationandmicroglialcellactivationtorescuedopaminergicneuronsinrodentmodelsofparkinsonsdisease
AT xiaoxiaofu adjustingvascularpermeabilityleukocyteinfiltrationandmicroglialcellactivationtorescuedopaminergicneuronsinrodentmodelsofparkinsonsdisease
AT hongjiang adjustingvascularpermeabilityleukocyteinfiltrationandmicroglialcellactivationtorescuedopaminergicneuronsinrodentmodelsofparkinsonsdisease
AT shuhan adjustingvascularpermeabilityleukocyteinfiltrationandmicroglialcellactivationtorescuedopaminergicneuronsinrodentmodelsofparkinsonsdisease
_version_ 1718376970327162880